Dr Reddys Laboratories receives EIR for its facility at Bachupally, Hyderabad
From USFDA
Dr Reddys Laboratories has received an Establishment Inspection Report from the USFDA on 11 December 2017 following closure of audit of its Formulations Manufacturing Plant 3 at Bachupally, Hyderabad by the USFDA, where in the Company received a Form 483 with 11 observations.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content